跳至主要内容
临床试验/NCT02314962
NCT02314962终止不适用

Diagnostic and Clinical Accuracy of Integrated Magnetic Resonance Imaging and Computed Tomography Perfusion in PET/MRI in Comparison to PET/CT in Solid Tumors

University of Zurich1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
43
试验地点
1
主要终点
Measurement of blood flow, blood volume and transfer constant (Ktrans) with CT-Perfusion and PET/MR-perfusion in solid tumors.

研究概览

简要总结

Diagnostic comparison between PET/CT and PET/MRI with integrated perfusion measurement in CT and MR. Study aim is to gain knowledge about additional value of CT perfusion and MR perfusion in solid tumors concerning tumor physiology, diagnostic accuracy and possibly prognostic.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
30 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • indication as stated above
  • written informed consent
  • patients with suspected or confirmed solid malignant tumors of the neck, chest or abdomen who have an indication for a PET/CT

排除标准

  • pregnant or breast feeding women
  • non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia)
  • Inclusion in another clinical trial 30 days prior to inclusion
  • age < 30years
  • contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia
  • known allergies to contrast CT or MRI contrast media
  • patients with an glomerular filtration rate of < 60ml/min/1.73m2

结局指标

主要结局

Measurement of blood flow, blood volume and transfer constant (Ktrans) with CT-Perfusion and PET/MR-perfusion in solid tumors.

时间窗: 18 months

次要结局

  • Correlation of blood flow, blood volume and transfer constant (Ktrans) measured with CT-Perfusion and PET/MR-perfusion with progression free survival in solid tumors.(18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验